The European biopsy device market will continue to grow modestly through 2028, driven largely by growth in the percutaneous soft tissue biopsy device market. In addition, the ongoing shift from reusable to disposable devices, coupled with improved patient perceptions surrounding biopsy procedures and screening tests, will have a significant positive impact on the market; overall, these factors will support continued market growth during the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in Europe across a 10-year period.
The European biopsy device market will continue to grow modestly over the forecast period, driven primarily by participation in cancer screening programs.
What cancer screening programs have been launched in recent years and how have they impacted the market?
How are CRC screening programs affecting market dynamics in Europe?
How are breast cancer screening programs affecting market dynamics in Europe?
Minimally invasive, alternative technologies to tissue biopsy are being adopted by physicians in the Europe.
To what extent are physicians adopting these minimally invasive technologies?
How will the adoption of alternative technologies impact the biopsy device market?
The ongoing shift in preference from reusable to disposable devices in Europe will have a significant impact on the biopsy device market.
How do adoption rates of reusable and disposable biopsy devices vary in each of the countries covered?
How will these varying adoption rates affect the revenues generated across different European markets?
- Biopsy Devices - Market Insights - Europe
Author(s): P Prasad, MS
Prasad Pallemsetty is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in the fields of gastroenterology, bariatrics, diabetes, ENT and bronchoscopy, gynecology, and urology. In particular, he has extensive knowledge of endoscopic devices, laparoscopic devices, and minimally invasive procedures. Prasad has attended many international conferences, including ENDOCON 2016 in Mumbai and Diabetes India 2018 in Kolkata, where he gained insight into the latest trends in endoscopic gastroenterology and diabetes treatments, respectively. Prasad holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmaceutics.
Follow Prasad on Twitter: @PPrasad_DRG